Cited by 214Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.

The absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis of 129 studies

Open access
Dennison, Rebecca A., Chen, Eileen S., Green, Madeline E., Legard, Chloe, Kotecha, Deeya, Farmer, George, Sharp, Stephen J., Ward, Rebecca J., Usher-Smith, Juliet A., Griffin, Simon J.·2021·Diabetes Research and Clinical Practice

Abstract

Aims To estimate development of type 2 diabetes (T2DM) in women with previous gestational diabetes (GDM) and investigate characteristics associated with higher diagnoses, building on previous meta-analyses and exploring heterogeneity. Methods Systematic literature review of studies published up to October 2019. We included studies reporting progression to T2DM ≥6 months after pregnancy, if diagnostic methods were reported and ≥50 women with GDM participated. We conducted random-effects meta-analyses and meta-regression of absolute and relative T2DM risk. PROSPERO ID: CRD42017080299. Results In 129 included studies, the percentage diagnosed with T2DM was 12% (95% confidence interval 8–16%) higher for each additional year after pregnancy, with a third developing diabetes within 15 years. Development was 18% (5–34%) higher per unit BMI at follow-up, and 57% (39–70%) lower in White European populations compared to others (adjusted for ethnicity and follow-up). Women with GDM had a relative risk of T2DM of 8.3 (6.5–10.6). 17.0% (15.1–19.0%) developed T2DM overall, although heterogeneity between studies was substantial (I 2 99.3%), and remained high after accounting for various study-level characteristics. Conclusions Percentage developing T2DM after GDM is highly variable. These findings highlight the need for sustained follow-up after GDM through screening, and interventions to reduce modifiable risk factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.diabres.2020.108625

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Research works printed but not linked: 2

  1. International Diabetes Federation Diabetes Atlas, 9th edition. 2019. Available from: www.diabetesatlas.org. Date last accessed: 01 Sept 2020.
  2. National Institute for Health Care and Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. NICE Clin Guidel 2015;13:2–65.

Cited by

Sorted by citations

Metadata

Authors
Dennison, R. A., Chen, E. S., Green, M. E., Legard, C., Kotecha, D., Farmer, G., Sharp, S. J., Ward, R. J., Usher-Smith, J. A., & Griffin, S. J.
Affiliations
University of Cambridge (GB)
Corresponding author
  • Dennison, Rebecca A.
  • Kotecha, Deeya
  • Farmer, George
  • Sharp, Stephen J.
  • Ward, Rebecca J.
  • Griffin, Simon J.
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
2021-01
Volume
171
Pages
108625
ISSN
0168-8227 (ISSN-L)
OpenAlex
W3111270620
Cited by
214
References
46
Citations by year
2026: 56 · 2025: 47 · 2024: 39 · 2023: 27 · 2022: 31 · 2021: 14
FWCI
2.13
Type
journal article
Language
en
Open access
Locations
  • Diabetes Research and Clinical Practice (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
  • Apollo
Funders
  • Cancer Research UK (A21464, 21464)
  • Medical Research Council (MC_UU_12015/4)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, type 2 diabetes, postpartum diabetes risk, diabetes progression, body mass index, ethnicity, racial disparities, diabetes screening, risk factors
MeSH terms
Adolescent, Adult, Diabetes Mellitus, Type 2, Female, Humans, Mass Screening, Pregnancy, Risk, Risk Factors, Diabetes, Gestational, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review